Etomidate for critically ill patients. Pro: Yes we can use it

European Journal of Anaesthesiology

Volumn 29, Issue 11, 2012, Pages 506-510

  Ray, David C ^a   McKeown, Dermot W ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Adrenal function; Anaesthetics; Critical illness; Etomidate; Intravenous; Patient outcome

Indexed keywords

ETOMIDATE; KETAMINE; MIDAZOLAM;

ADRENAL INSUFFICIENCY; ADRENAL SUPPRESSION; ANESTHESIA INDUCTION; CRITICALLY ILL PATIENT; DRUG CHOICE; DRUG EFFECT; DRUG SAFETY; DRUG USE; HUMAN; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; TREATMENT OUTCOME;

ADRENAL INSUFFICIENCY; ANESTHETICS, INTRAVENOUS; CRITICAL ILLNESS; ETOMIDATE; HUMANS; HYPOTENSION; SEPSIS; SEVERITY OF ILLNESS INDEX;

EID: 84868542411     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e32835819b0     Document Type: Review

References (62)

1. Forman SA. Clinical and molecular pharmacology of etomidate. Anesthesiology 2011; 114:695-707.
2. McCollum JSC, Dundee JW. Comparison of induction characteristics of four intravenous anaesthetic agents. Anaesthesia 1986; 41:995-1000.
3. Morel J, Salard M, Castelain C, et al. Haemodynamic consequences of etomidate administration in elective cardiac surgery: a randomized doubleblinded study. Br J Anaesth 2011; 107:503-509.
4. Reich DL, Hossain S, Krol M, et al. Predictors of hypotension after induction of general anesthesia. Anesth Analg 2005; 101:622-628.
5. Ray DC, McKeown DW. Emergency tracheal intubation: more than just technical skill. Resuscitation 2011; 82:505-506.
6. Bergen JM, Smith DC. A review of etomidate for rapid sequence intubation in the emergency department. J Emerg Med 1997; 15:221-230.
7. Baird CRW, Hay AW, McKeown DW, Ray DC. Rapid sequence induction in the emergency department: induction drug and outcome of patients admitted to the intensive care unit. Emerg Med J 2009; 26:576-579.
8. RayDC,McKeownDW.Effect of induction agent on vasopressor and steroid use, and outcome in patients with septic shock. Crit Care 2007; 11:R56.
9. Ray DC, Hay AW, McKeown DW. Induction drug and outcome of patients admitted to the intensive care unit after emergency laparotomy. Eur J Anaesthesiol 2010; 27:481-485.
10. Jaber S, Amraoui J, Lefrant J-Y, et al. Clinical practice and risk factors for immediate complications of endotracheal intubation in the intensive care unit: a prospective, multiple-centre study. Crit Care Med 2006; 34:2355-2361.
11. Simpson GD, Ross MJ, McKeown DW, Ray DC. Tracheal intubation in the critically ill: a multicentre national study of practice and complications. Br J Anaesth 2012; 108:792-799.
12. Schwartz DE, Matthay MA, Cohen NH. Death and other complications of emergency airway management in critically ill adults: a prospective investigation of 297 tracheal intubations. Anesthesiology 1995; 82:367-376.
13. Jones AE, Yiannibas V, Johnson C, Kline JA. Emergency department hypotension predicts sudden unexpected in-hospital mortality: a prospective cohort study. Chest 2006; 130:941-946.
14. Jeremitsky E, Omert L, Dunham CM, et al. Harbingers of poor outcome the day after severe brain injury: hypothermia, hypoxia, and hypoperfusion. J Trauma 2003; 54:312-319.
15. Arbous MS, Grobbee DE, van Kleef JW, et al. Mortality associated with anaesthesia: a qualitative analysis to identify risk factors. Anaesthesia 2001; 56:1141-1153.
16. Bijker J, Persoon S, Peelen L, et al. Intraoperative hypotension and perioperative ischemic stroke after general surgery: a nested case-control study. Anesthesiology 2012; 116:658-664.
17. Combes X, Jabre P, Margenet A, et al. Unanticipated difficult airway management in the prehospital emergency setting. Anesthesiology 2011; 114:105-110.
18. Jabre P, Combes X, Lapostolle F, et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet 2009; 374:293-300.
19. Oglesby AJ. Should etomidate be the induction agent of choice for rapid sequence intubation in the emergency department? Emerg Med J 2004; 21:655-659.
20. Jaber S, Jung B, Corne P, et al. An intervention to decrease complications related to endotracheal intubation in the intensive care unit: a prospective, multiple-centre study. Intensive Care Med 2010; 36:248-255.
21. Martin LD, Mhyre JM, Shanks AM, et al. 3423 emergency tracheal intubations at a university hospital. Airway outcomes and complications. Anesthesiology 2011; 114:42-48.
22. Wagner RL, White PF, Kan PB, et al. Inhibition of adrenal steroidogenesis by the anesthetic etomidate. N Engl J Med 1984; 310:1536-1542.
23. Duthie DJR, Fraser R, Nimmo WS. Effect of induction of anaesthesia with etomidate on corticosteroid synthesis in man. Br J Anaesth 1985; 57:156-159.
24. Diago MC, Amado JA, Otero M, Lopez-Cordovilla JJ. Antiadrenal action of a subanaesthetic dose of etomidate. Anaesthesia 1988; 43:644-645.
25. Absalom A, Pledger D, Kong A. Adrenocortical function in critically ill patients 24 h after a single dose of etomidate. Anaesthesia 1999; 54:861-867.
26. Malerba G, Romano-Girard F, Cravoisy A, et al. Risk factors of relative adrenocortical deficiency in intensive care patients needing mechanical ventilation. Intensive Care Med 2005; 31:388-392.
27. Vinclair M, Broux C, Faure P, et al. Duration of adrenal inhibition following a single dose of etomidate in critically ill patients. Intensive Care Med 2008; 34:714-719.
28. Den Brinker M, Hokken-Koelega ACS, Hazelet JA, et al. One single dose of etomidate negatively influences adrenocortical performance for at least 24 h in children with meningococcal sepsis. Intensive Care Med 2008; 34:163-168.
29. Payen J-F, Dupuis C, Trouve-Buisson T, et al. Corticosteroid after etomidate in critically ill patients: a randomized controlled trial. Crit Care Med 2012; 40:29-35.
30. Annane D. Etomidate and intensive care physicians. Intensive Care Med 2005; 31:1454.
31. Marik PE, Pastores SM, Annane D, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statement from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008; 36:1937-1949.
32. Marik PE, Zaloga GP. Adrenal insufficiency during septic shock. Crit Care Med 2003; 31:141-145.
33. Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for patients with septic shock. New Engl J Med 2008; 358:111-124.
34. Albert SG, Ariyan S, Rather A. The effect of etomidate on adrenal function in critical illness: a systematic review. Intensive Care Med 2011; 37:901-910.
35. Siraux V, de Backer D, Yalavatti G, et al. Relative adrenal insufficiency in patients with septic shock: comparison of low-dose and conventional corticotrophin tests. Crit Care Med 2005; 33:2479-2486.
36. Cotton BA, Guillamondegui OD, Fleming SB, et al. Increased risk of adrenal insufficiency following etomidate exposure in critically ill patients. Arch Surg 2008; 143:62-67.
37. Mohammad Z, Afessa B, Finkielman JD. The incidence of relative adrenal insufficiency in patients with septic shock after the administration of etomidate. Crit Care 2006; 10:R105.
38. Hildreth AN, Mejia VA, Maxwell RA, et al. Adrenal suppression following a single dose of etomidate for rapid sequence induction: a prospective randomized study. J Trauma 2008; 65:573-579.
39. Cuthbertson BH, Sprung CL, Annane D, et al. The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock. Intensive Care Med 2009; 35:1868-1876.
40. Annane D. ICU physicians should abandon the use of etomidate!. Intensive Care Med 2005; 31:325-326.
41. Morris C, McAllister C. Etomidate for emergency anaesthesia: mad, bad and dangerous to know? Anaesthesia 2005; 60:737-740.
42. Walls RM, Murphy MF. Continue to use etomidate for intubation of patients with septic shock. Ann Emerg Med 2008; 52:13-14.
43. Majesko A, Darby JM. Etomidate and adrenal insufficiency: the controversy continues. Crit Care 2010; 14:338.
44. Pallin DJ, Walls RM. Letter to Cuthbertson et al. Intensive Care Med 2010; 36:1268.
45. Jackson WL. Should we use etomidate as an induction agent for endotracheal intubation in patients with septic shock? A critical appraisal. Chest 2005; 127:1031-1038.
46. Kulstad EB, Kalimullah EA, Tekwani KL, Courtney DM. Etomidate as an induction agent in septic patients: red flags or false alarms? West J Emerg Med 2010; 11:161-172.
47. Hohl CM, Kelly-Smith CH, Yeung TC, et al. The effect of a bolus dose of etomidate on cortisol levels, mortality, and health services utilization: a systematic review. Ann Emerg Med 2010; 56:105-113.
48. Murray H, Marik PE. Etomidate for endotracheal intubation in sepsis: acknowledging the good while accepting the bad. Chest 2005; 127:707-709.
49. Den Brinker M, Joosten KF, Liem O, et al. Adrenal insufficiency in meningococcal sepsis: bioavailable cortisol levels and impact of interleukin-6 levels and intubation with etomidate on adrenal function and mortality. J Clin Endocrinol Metab 2005; 90:5110-5117.
50. Lipiner-Friedman D, Sprung CL, Laterre PF, et al. Adrenal function in sepsis: the retrospective Corticus cohort study. Crit Care Med 2007; 35:1012-1018.
51. Riché FC, Boutron CM, Valleur P, et al. Adrenal response in patients with septic shock of abdominal origin: relationship to survival. Intensive Care Med 2007; 33:1761-1766.
52. Tekwani KL, Watts HF, Rzechula KH, et al. A prospective observational study of the effect of etomidate on septic patient mortality and length of stay. Acad Emerg Med 2009; 16:11-14.
53. Dmello D, Taylor S, O'Brien J, Matuschak GM. Outcomes of etomidate in severe sepsis and septic shock. Chest 2010; 138:1327-1332.
54. Ehrman R, Wira C, Lomax A, et al. Etomidate in severe sepsis and septic shock patients does not contribute to mortality. Intern Emerg Med 2011; 6:253-257.
55. Kim TY, Rhee JE, Kim KS, et al. Etomidate should be used carefully for emergent endotracheal intubation in patients with septic shock. J Korean Med Sci 2008; 23:988-991.
56. De Jong MFC, Beishuizen A, Spijkstra J-J, et al. Predicting a low cortisol response to adrenocorticotrophin hormone in the critically ill: a retrospective cohort study. Crit Care 2007; 11:R61.
57. Tekwani KL, Watts HF, Sweis RT, et al. A comparison of the effects of etomidate and midazolam on hospital length of stay in patients with suspected sepsis: a prospective, randomized study. Ann Emerg Med 2010; 56:481-489.
58. Watt I, Ledingham IMcA. Mortality amongst multiple trauma patients admitted to an intensive therapy unit. Anaesthesia 1984; 39:973-981.
59. Girard TD, Kress JP, Fuchs BD, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet 2008; 371:126-134.
60. Annane D, Sé bille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288:862-871.
61. Schenarts CL, Burton JH, Riker RR. Adrenocortical dysfunction following etomidate induction in emergency department patients. Acad Emerg Med 2001; 8:1-7.
62. Jones AE. The etomidate debate. Ann Emerg Med 2010; 56:490-491.